Benchmark Affirms Buy on Lucid, $5 Price Target

Analyst: Mickey Legg 1 min read Reproduced verbatim Published as The Benchmark Company, now part of StoneX
Rating
Buy
Unchanged
Target
$5
Unchanged
Outcome
Missed
within 12 months

StoneX’s latest target on Lucid is now $30 (Feb 19, 2026); the median of 6 firms is $4.50. StoneX has reached 71% of its year-old targets (24 scored).

StoneX and Lucid logos

What the analyst said

Benchmark analyst Mickey Legg reiterated a Buy rating and $5.00 price target on Lucid Group Inc. (NASDAQ: LCID).

“After meeting with LCID’s CFO Taoufiq Boussaid on Tuesday and reviewing 2Q production and deliveries, we remain confident in the company’s path to scale, underpinned by $5.7B of total liquidity, manufacturing flexibility, and leading technology.

LCID delivered 3,309 vehicles in 2Q25, slightly below our estimate of 3,694, but up 38% YoY. The company produced 3,863 vehicles in the quarter and reiterated full-year production guidance of 20,000 units. Demand for the new Gravity SUV remains strong, and deliveries are expected to accelerate in the second half as production stabilizes.

We forecast 16,776 deliveries for the year, up 63.8% YoY. While we do not expect LCID to reach gross profitability before 2027, requiring sustained quarterly deliveries above 12,000 units, we believe the upcoming Midsize platform, with SOP targeted for late 2026, will support meaningful volume growth beyond current levels.

We remain focused on the following catalysts: scaling deliveries, managing tariff impacts, unveiling the Midsize platform, advancing AI and autonomy, and monetizing technology licensing opportunities. Maintain Buy and $5.00 price target.”

Price Target note: Lucid completed a 1-for-10 reverse stock split on September 2, 2025. The price targets in this note predate the split and are quoted in pre-split share terms; multiply them by 10 to compare with the share price after the split.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LCID trades at $3.26. The 6 analysts who set a target in the last 3 months range from $3 to $9, with a median of $4.50. This $5 target is 11% above the median.

Since the note LCID has moved −86% (from $22.80). The 12-month window closed on July 10, 2026.

Track record

This call✗ Not reached within 12 months: a year after the note LCID closed at $5.55, 89% below the $50 target, and it moved the other way. Prices are split-adjusted.

Firm track recordStoneX: 71% of its 24 targets at least a year old were reached within 12 months (#18 of 26 firms); on Lucid, 0 of 3. Accuracy ranking →

StoneX on Lucid

StoneX price targets on Lucid

8 calls from February 12, 2025 to November 13, 2025. The target went from $5 to $3 (−40%). The rating stayed Buy.

StoneX target
  1. November 13, 2025Target cut from $7 (−57%)Buy$3
  2. August 6, 2025Kept the $7 targetBuy$7
  3. July 17, 2025Kept the $7 targetBuy$7
  4. July 17, 2025Target raised from $5 (+40%)Buy$7
  5. July 10, 2025 This noteKept the $5 targetBuy$5
  6. April 4, 2025Kept the $5 targetBuy$5
  7. March 7, 2025Kept the $5 targetBuy$5
  8. February 12, 2025Earliest call shownBuy$5

Targets are adjusted for the 1-for-10 reverse split on Sep 2, 2025, so every call is in the same share terms as this note.

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.